Eric Pauwels is CHIEF EXECUTIVE OFFICER of PTC THERAPEUTICS, INC.. Currently has a direct ownership of 86,805 shares of PTCT, which is worth approximately $3.67 Million. The most recent transaction as insider was on Apr 19, 2021, when has been sold 786 shares (Common Stock) at a price of $48.17 per share, resulting in proceeds of $37,862. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 86.8K
28.23% 3M change
94.86% 12M change
Total Value Held $3.67 Million

Eric Pauwels Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 19 2021
SELL
Open market or private sale
$37,862 $48.17 p/Share
786 Reduced 2.15%
35,701 Common Stock
Feb 01 2021
SELL
Open market or private sale
$20,620 $56.96 p/Share
362 Reduced 0.98%
36,487 Common Stock
Jan 25 2021
SELL
Open market or private sale
$26,744 $62.05 p/Share
431 Reduced 1.16%
36,849 Common Stock
Jan 06 2021
BUY
Grant, award, or other acquisition
-
10,200 Added 21.48%
37,280 Common Stock
Jan 05 2021
SELL
Open market or private sale
$66,549 $62.37 p/Share
1,067 Reduced 3.79%
27,080 Common Stock
Nov 03 2020
SELL
Open market or private sale
$349,961 $56.5 p/Share
6,194 Reduced 18.3%
27,647 Common Stock
EP

Eric Pauwels

CHIEF EXECUTIVE OFFICER
South Plainfield, NJ

Track Institutional and Insider Activities on PTCT

Follow PTC THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTCT shares.

Notify only if

Insider Trading

Get notified when an Ptc Therapeutics, Inc. insider buys or sells PTCT shares.

Notify only if

News

Receive news related to PTC THERAPEUTICS, INC.

Track Activities on PTCT